Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tangningtongluo Tablet for Non‑Proliferative Diabetic Retinopathy
ChiCTR2100049803Phase 2Completed
- Sponsor
- Ineye Hospital of Chengdu University of Traditional Chinese Medicine
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of tangningtongluo in diabetic retinopathy (DR) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Ineye Hospital of Chengdu University of Traditional Chinese Medicine. Primary endpoints: Best corrected visual acuity and Digital x-ray system progression rate. Started Aug 2021; status: completed.
02
Drugs
tangningtongluo
03
Conditions
diabetic retinopathy (DR)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2100049803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049803.